To verify that the effects of PHA-793887 were due to its inhibition of CDK1 in osteosarcoma cells, we assessed CDK1 levels using Western blotting and an enzyme-linked immunosorbent assay (ELISA). This evidence concerns the gene CDK1 and osteosarcoma.